How does cardiac Remodelling occur?
This remodeling occurs due to mechanical stress on the heart muscle produced by the underlying disease process. In the early stages of a heart attack, some degree of remodeling can help the ventricle compensate for the damage that has occurred.
What is myocardial Remodelling?
Myocardial remodeling (REM) is a deleterious process characterized by gradual cardiac enlargement, cardiac dysfunction and typical molecular changes. It is a universal phenomenon, being caused by many pathological conditions [1, 2]. Of these, myocardial infarction is the more common.
What happens during ventricular remodeling?
Remodeling involves myocyte hypertrophy and alterations in ventricular architecture to distribute the increased wall stresses more evenly as the extracellular matrix forms a collagen scar to stabilize the distending forces and prevent further deformation.
What causes ventricular remodeling?
In response to pathophysiological stimuli such as ischemia/reperfusion or excessive mechanical load, multiple molecular and cellular processes contribute to ventricular remodeling. These include cardiomyocyte loss through cell death pathways such as necrosis, apoptosis, or possibly excessive autophagy.
What is reverse cardiac Remodelling?
The term ‘reverse remodeling’ was introduced by Kass and colleagues in a study of cardiac myoplasty,14 in which the latissimus dorsi muscle was wrapped around a heart and paced synchronously with ventricular systole in an effort to enhance systolic function.
What are cardiac remodeling drugs?
The neurohormonal antagonists that have been demonstrated to reduce mortality and morbidity in HF (angiotensin-converting enzyme inhibitors [ACE], beta-blockers, angiotensin receptor blockers, and aldosterone antagonists) are also able to inhibit or reverse remodeling.
What is atrial remodeling?
Atrial arrhythmogenic remodeling, defined as any change in atrial structure or function that promotes atrial arrhythmias, is central to AF. Remodeling can be due to underlying cardiac conditions, systemic processes and conditions such as aging, or AF itself.
What is pathological remodeling?
From Wikipedia, the free encyclopedia. In cardiology, ventricular remodeling (or cardiac remodeling) refers to changes in the size, shape, structure, and function of the heart. This can happen as a result of exercise (physiological remodeling) or after injury to the heart muscle (pathological remodeling).
How do ACE inhibitors prevent cardiac remodeling?
ACE inhibitors are known to increase tissue bradykinin accumulation. Bradykinin has antigrowth effects and reduces vasomotor tone. Increased kinin activation resulting from ACE inhibition may attenuate structural remodelling in the infarcted heart.
Which drug can help limit cardiac remodeling?
How do ACE inhibitors stop cardiac remodeling?
What is left atrial remodeling?
Left atrial (LA) remodeling refers to the spectrum of pathophysiological changes in atrial structure and mechanical function and the electric, ionic, and molecular milieu of the LA that most often occurs in response to stresses imposed by conditions such as hypertension, heart failure, diabetes mellitus, and obesity.
What is pathologic remodelling of the heart?
pathological remodelling may occur after conditions such as myocardial infarction (pressure overload), inflammatory myocardial disease, with idiopathic dilated cardiomyopathy, or with volume overload. The cardiac cell that is particularly involved in the remodelling process is the cardiomyocyte.
What is cardiac remodeling?
Dr. Ali is also an award-winning writer. Cardiac remodeling is a term that refers to changes in the heart’s size and shape that occur in response to cardiac disease or cardiac damage. When doctors talk about “remodeling,” they are usually talking about the left ventricle, though occasionally this term is applied to other cardiac chambers.
What are the mechanisms of pathological ventricular remodeling?
Mechanisms of pathological ventricular remodeling. In response to pathophysiological stimuli such as ischemia/reperfusion or excessive mechanical load, multiple molecular and cellular processes contribute to ventricular remodeling. These include cardiomyocyte loss through cell death pathways such as necrosis, apoptosis,…
What are the strategies for pharmacologic treatment of cardiac remodeling?
Pharmacological treatment of cardiac remodeling can be divided by three strategy stages: consolidated, promising and potential strategies (Figure 3). Open in a separate window Figure 3